Rare diseases affect fewer than 1 in 2000 people individually — but collectively, they affect approximately 8% of Australians (over 2 million people). Most rare diseases are genetic, many are serious and progressive, most have no cure, and nearly all are underfunded relative to their individual and collective impact. Understanding the funding landscape helps rare disease patient organisations, researchers, families, and funders navigate this complex ecosystem.
Scale
Impact
Research investment gap
Rare diseases attract proportionally far less research investment than common diseases — the "orphan" drug and research problem:
- Small patient populations make clinical trials difficult
- Limited commercial incentive for industry
- Government research agencies struggle to prioritise across thousands of conditions
NHMRC
The National Health and Medical Research Council funds some rare disease research:
- Open competitive grant rounds (rare disease proposals compete with all others)
- Specific rare disease initiatives (some targeted calls)
- Investigator grants for rare disease researchers
- Centres of Research Excellence
Rare Voices Australia
Rare Voices Australia is the peak body for the rare disease community:
- Advocacy for policy and research investment
- Patient organisation support
- Government engagement
- Not primarily a grantmaker but a connector and advocate
National Institutes of Health (NIH) and international
Australian researchers compete for NIH grants — significant source of rare disease research funding.
Medical Research Future Fund (MRFF)
MRFF has funded rare disease research through specific initiatives:
- Rare Diseases Mission
- Genetic research
- Genomics for diagnosis
Genomics and precision medicine investment
Australian Genomics and state genomics initiatives fund genetic rare disease diagnosis and research.
Each major rare disease has one or more charitable foundations:
Examples by condition
These foundations are simultaneously:
- Patient and family support organisations
- Research funders (disease-specific grants)
- Advocacy organisations (TGA, PBS listing, policy)
- Community builders
Many people with rare diseases have disabilities — and may access NDIS support:
- NDIS covers supports related to functional impact of rare conditions
- Planning for NDIS can be complex for rare disease given fluctuating needs
- Some rare disease organisations provide NDIS navigation support
Research grants
Disease-specific foundation research grants:
- Laboratory research
- Clinical studies
- Natural history studies (characterising disease course)
- Biobank development
- Clinical trial support
- Registry development
Patient registries
National patient registries enable research by connecting researchers with patients:
- Registry development and maintenance
- Patient consent and data management
- International registry collaboration
Diagnostic support
Reducing the diagnostic odyssey:
- Genetic counselling
- Whole genome/exome sequencing
- Rare disease diagnostic clinics
- International diagnostic consultation
Patient and family support
Awareness and advocacy
Workforce development
Training doctors and allied health in rare disease:
- Rare disease training for GPs
- Allied health rare disease resources
- Telemedicine for rare disease (connecting patients to distant specialists)
The numbers problem
Small patient populations mean small numbers of beneficiaries. Funders used to large-scale programmes may struggle with proposals benefiting 20 or 50 families. Address this head-on: explain the severity of impact, the absence of alternatives, and the leverage of research (one breakthrough benefits all patients globally).
Research to treatment pipeline
Funders with finite resources are more compelling when research has a plausible pathway to treatment. Show how proposed research could lead to treatment development.
International collaboration
Many rare disease research programmes are international by necessity — small patient populations require multisite studies. Show international collaborations.
Community voice
Rare disease patient organisations are often family-founded and community-led — this lived experience leadership is a strength, not a weakness. Feature it.
Long-term commitment
Rare disease research requires long-term commitment — not one-year grants but sustained investment. Where possible, show multi-year funding or committed organisational sustainability.
Tahua's grants management platform supports disease-specific foundations and rare disease funders — with research grant management, patient registry support, family support programme tracking, and the reporting tools that help rare disease funders demonstrate their contribution to better outcomes for Australia's rare disease community.